Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Prostate cancer is a high-incidence cancer that requires improved patient stratification to ensure accurate predictions of risk and treatment response. Due to the significant contributions of transcription factors and epigenetic regulators to prostate cancer progression, there has been considerable progress made in developing gene signatures that may achieve this. Some of these are aligned to activities of key drivers such as the androgen receptor, whilst others are more agnostic. In this review, we present an overview of these signatures, the strategies for their derivation, and future perspectives on their continued development and evolution.

Original publication

DOI

10.3390/cancers13030495

Type

Journal article

Journal

Cancers (Basel)

Publication Date

28/01/2021

Volume

13

Keywords

biobanking, biomarkers, chromatin, computational biology, epigenetics, prognostication, prostate cancer, signatures, stratification, transcription factors